Magnetic particles having one or more fluorescence detectable moieties positioned asymmetrically with respect to the magnetic pole regions of the particle for using in detecting and characterizing an analyte; magnetic relaxation immunoassay; ligand-receptor binding determination
Inventors
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Compositions and methods relating to magnetic particles comprising one or more fluorescence detectable moieties positioned asymmetrically with respect to the magnetic pole regions of the particles are described. The compositions are useful for detecting analytes.
Core Innovation
The disclosure provides magnetic particles with stable north and south-pole magnetic regions and one or more fluorescent moieties covalently linked to the magnetic particle. The fluorescent moieties are positioned with an asymmetric spatial localization with respect to the stable north- and south-pole regions, and anti-ligand molecules are covalently linked to the magnetic particle to enable ligand binding determination.
In the presence of the ligand analyte, the ligand binds to the anti-ligand molecules at the magnetic particle surface and increases the rotational drag of the fluorescence-detectable composition when placed in an alternating or rotating electromagnetic field. The method irradiates the composition with a fluorescence-excitation light beam while rotating the composition in the field.
Detection is based on determining, from a measured phase lag of fluorescence emission relative to the composition prior to ligand binding, the presence and/or amount of ligand bound to the analyte. The disclosure also includes configurations for evanescent excitation and multi-analyte detection using mixed particle populations with different emission colors.
Claims Coverage
The partial content contains two independent claims. The claims center on a fluorescence-detectable magnetic particle composition with asymmetric fluorescent localization relative to stable north/south magnetic regions, anti-ligand-mediated ligand binding that increases rotational drag in an alternating or rotating electromagnetic field, and detection by phase lag of fluorescence emission.
Asymmetric fluorescent magnetic particles with covalently linked anti-ligand
A fluorescence-detectable composition comprising a magnetic particle having stable north and south-pole magnetic regions; one or more fluorescent moieties covalently linked to the magnetic particle and having an asymmetric spatial localization with respect to said north- and south-pole regions; and anti-ligand molecules covalently linked to the magnetic particle.
Phase-lag fluorescence detection under alternating or rotating electromagnetic field
Irradiating the composition with a fluorescence-excitation light beam while rotating the composition in an alternating or rotating electromagnetic field; and determining, from a measured phase lag of fluorescence emission from the composition relative to the composition prior to ligand binding, the presence and/or amount of ligand bound to the analyte.
Binding-induced rotational drag and ligand detection
Exposing an analyte in solution to the fluorescence-detectable composition by binding the ligand analyte to the surface of said magnetic particle, thereby to increase the rotational drag of the composition when placed in an alternating or rotating electromagnetic field.
The inventive features combine asymmetric fluorescent localization on magnetic particles, anti-ligand-mediated ligand binding, rotational drag changes in an alternating or rotating electromagnetic field, and phase-lag-based determination of ligand presence and amount.
Stated Advantages
Determines the presence and/or amount of ligand bound to the analyte from a measured phase lag of fluorescence emission relative to the composition prior to ligand binding.
Documented Applications
Detecting the presence of a ligand analyte and determining its amount via a magnetic relaxation immunoassay (MARIA) based on analyte binding-induced changes in rotational drag and fluorescence phase lag.
Selective detection for multiple analytes using mixed particle populations with different emission colors.
Matrix display/screen pixel embodiments based on orientation-dependent fluorescence.
Interested in licensing this patent?